Tooth count tied to longer pancreatic cancer survival
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Hiroshima University researchers found pancreatic cancer surgery patients with 21 or more natural teeth had median overall survival of 60.7 months, versus 39.1 months for those with 20 or fewer — a roughly 21-month gap.
- The study enrolled 339 consecutive patients who underwent radical pancreatectomy at Hiroshima University Hospital between 2014 and 2022, with each receiving a dental examination before surgery.
- The survival advantage held even after adjusting for tumor stage, lymph node metastasis, surgical margins, chemotherapy, and nutritional status — variables that usually explain most outcome differences.
- Counterintuitively, chewing function itself (measured by posterior teeth occlusion) was not independently tied to survival, suggesting tooth count acts as a marker of systemic health rather than a measure of how well someone eats.
- Researchers propose tooth loss reflects lifelong chronic inflammation, frailty, nutritional condition, and systemic vulnerability — a concept corresponding author Kenichiro Uemura summarized as "the mouth may reflect the body's long-term resilience."
- Published in the Journal of Hepato-Biliary-Pancreatic Sciences, the study came from a single-center, Japanese-only cohort; the team says multicenter and international validation is required before clinical adoption.
- The team plans next to investigate how oral bacteria such as Porphyromonas gingivalis might biologically link chronic periodontal inflammation to pancreatic tumor progression.
Why it matters: A nearly two-year survival gap tied solely to natural tooth count — and persisting after controlling for tumor stage, chemotherapy, and nutrition — suggests a routine pre-operative dental exam captures a dimension of patient resilience that standard oncology workups miss. If validated internationally, the marker would give surgeons a near-zero-cost input for pancreatic cancer risk stratification, the researchers' stated goal.
Ask SkimNews
